Moody Lynn & Lieberson’s ContraFect Corporation CFRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-125
Closed -$2K 241
2022
Q3
$2K Hold
125
﹤0.01% 216
2022
Q2
$31K Hold
125
﹤0.01% 217
2022
Q1
$37K Hold
125
﹤0.01% 226
2021
Q4
$26K Buy
+125
New +$34.3K ﹤0.01% 233

Other funds holding CFRX

Moody Lynn & Lieberson's CFRX Position: Q4 2022 in Review

Moody Lynn & Lieberson sold out of ContraFect Corporation (CFRX) in Q4 2022, closing a stake of 125 shares — an estimated $2K sold.

Moody Lynn & Lieberson first reported a position in CFRX in Q4 2021 and held it in 4 quarters. The position peaked at $37K in Q1 2022. 40 funds tracked by Wall St. Rank hold CFRX as of Q4 2022.

  • Moody Lynn & Lieberson reported no remaining ContraFect Corporation position as of Q4 2022 after selling out during the quarter.
  • Moody Lynn & Lieberson sold 125 ContraFect Corporation shares in Q4 2022, an estimated $2K.
  • Moody Lynn & Lieberson first reported a position in ContraFect Corporation in Q4 2021 and held it in 4 quarters.
  • Moody Lynn & Lieberson's ContraFect Corporation position peaked at $37K in Q1 2022.
  • 40 funds tracked by Wall St. Rank held ContraFect Corporation as of Q4 2022.

Based on Moody Lynn & Lieberson's 13F filing for Q4 2022, filed 1 Feb 2023.